|
|
 |
|
Viewing report
|
|
|
|
The Outlook for Cardiovascular Risk Factors: Epidemiology, market and pipeline analysis
Business Insights, Feb 2004, Pages: 176
The Outlook for Cardiovascular Risk Factors: Epidemiology, market and pipeline analysis, evaluates current and future growth prospects for pharma companies to 2008 in five major cardiovascular risk factors that can be moderated by pharmacotherapy; hypertension, dyslipidemia, diabetes, obesity and smoking. Cumulatively, the value of these markets was approximately $66bn in 2002 or around one-fifth of the global pharmaceutical market. In the US alone, the direct and indirect costs of cardiovascular disease (CVD) and stroke in 2003 are estimated at almost $352bn. Reducing these costs by appropriately treating cardiovascular risk factors has become a major focus of the pharmaceutical industry and healthcare payors. This report sets out to define cardiovascular risk factors and how identifying links to them sooner, will lead to a decline in CVD, resulting in massive cost savings for both pharma companies and healthcare payors. Treating risk factors is preventive medicine at its most challenging and this report provides insights into the risk factors that pharma companies need to overcome this battle - it can be won...let this report help you.
Region: Global
Customers who bought this item also bought
Dyslipidemia: Opportunities in Cardiovascular Risk Reduction
Diabetes, Metabolic Syndrome and Cardiovascular Disease
Pipeline Insight: Dyslipidemia - Pipeline Agents Unlikely To Rejuvenate The Market
The World Diabetes Market, 2007-2025: An analysis of Diabetes Drug and Insulin Market
Potential for Cross-Risk Factor Combinations: Targeting Hypertension, Dyslipidemia and Diabetes
Stakeholder Insight: Diabetes
Metabolic Diseases Pipeline Analysis:Focus on Dyslipidemia, Diabetes, and Obesity
Treatment Algorithms: Hypertension 3rd Edition - Opportunities In Resistant and Hypertensive Sub-Populations
Competitor Analysis: Obesity & Diabetes
Pipeline Insight: Non-Insulin Antidiabetics – Incretin Mimetics – Leaders in a Diverse Pipeline
The Asian Cardiovascular Market Outlook to 2014: Regional and Therapeutic Analysis, Pipeline Impact and Growth Opportunities
The Cardiovascular Market Outlook to 2013: Competitive Landscape, Global Market Analysis and Pipeline Analysis
|
|
|
|
